VENUS REMEDIES Share price, NSE/BSE Forecast News and Quotes| Equitymaster
X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Markets will remain closed on 22nd August, 2018 on account of Bakri Id.

VENUS REMEDIES Share Price   (VSRM)

Here is the latest stock price and chart of VENUS REMEDIES. For more details, see the VENUS REMEDIES company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report.

REFRESH
Live BSE Quotes Aug 21, 2018 (Close)
Price (Rs)55.30 Open (Rs) 56.10 High (Rs) 57.70 Low (Rs) 55.00
% Change-0.54 Volume 22,262 Value (Rs) 1,239,991 52-Week H/L 125.90 / 41.50
Live NSE Quotes Aug 21, 2018 (Close)
Price (Rs)55.55 Open (Rs) 56.15 High (Rs) 57.70 Low (Rs) 55.00
% Change-0.71 Volume 38,736 Value (Rs) 2,175,906 52-Week H/L 126.00 / 42.25
Valuation
EPS (Rs)* -11.74 P/E Ratio (x) NM Market Cap (Rs m) 632.63 P/BV (x) 0.14
  *Trailing 12 months earnings, excluding extraordinary / exceptional items. BSE Sensex | CNX Nifty

Charts
Loading...
 
     
 S&P BSE SENSEX 
PERIOD
Advanced Charts new
Charts by TradingView

VENUS REMEDIES Share Price Today:

VENUS REMEDIES last traded price was down 0.5% to Rs 55.3 on the BSE. On the NSE, VENUS REMEDIES last traded price was down 0.7% to Rs 55.6. The total volume of shares traded was 0.1 m.

Overall, the broader S&P BSE HEALTHCARE Index was up by 1.1%. And the benchmark S&P BSE SENSEX was at 38,285.8 (up 0.0%).

Over the last 30 days, the VENUS REMEDIES share price is up 27.0%. And over the last one year, VENUS REMEDIES share price is down 37.3%.





Today's Market

Sensex, Nifty Close at Record Highs; Healthcare and Power Stocks Witness Buying(Closing)

Indian share markets continued to trade on a flat during closing hours of trade and ended the day marginally higher to close at fresh record high levels.

Related Views On News

VENUS REMEDIES Announces Quarterly Results (1QFY19); Net Profit Down 756.1% (Quarterly Result Update)

Aug 20, 2018 | Updated on Aug 20, 2018

For the quarter ended June 2018, VENUS REMEDIES has posted a net profit of Rs 56 m (down 756.1% YoY). Sales on the other hand came in at Rs 655 m (down 16.2% YoY). Read on for a complete analysis of VENUS REMEDIES's quarterly results.

VENUS REMEDIES Announces Quarterly Results (4QFY18); Net Profit Down 307.2% (Quarterly Result Update)

Jun 12, 2018 | Updated on Jun 12, 2018

For the quarter ended March 2018, VENUS REMEDIES has posted a net profit of Rs 94 m (down 307.2% YoY). Sales on the other hand came in at Rs 932 m (up 16.8% YoY). Read on for a complete analysis of VENUS REMEDIES's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

3 Reasons Why I Believe This Company Can Make It Big!(The 5 Minute Wrapup)

Aug 16, 2018

How consumer-facing businesses can multiply your wealth in the coming years.

Trading in These Times: 8% Gains in 3 Days!(Profit Hunter)

Aug 9, 2018

Here are 2 stocks you can buy right now! And there are plenty more opportunities to come...

Economic Growth was Faster During Manmohan Years Than Modi Years, But...(Vivek Kaul's Diary)

Aug 20, 2018

When it comes to the economy, both Modi and Manmohan have had their share of major screw ups.

Why HDFC Equity Fund Disappointed Its Investors(Outside View)

Aug 9, 2018

Though popular, HDFC Equity Fund is not among the best performers anymore. Here is the reason behind its underperformance that has left investors disappointed.

To Identify Pricing Power, Compare Companies Like This(Chart Of The Day)

Aug 10, 2018

Pricing power is the first tenet of an economic moat. If you see that in a company, do investigate to find an economic moat.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK VENUS REMEDIES

  • Track your investment in VENUS REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON VENUS REMEDIES

VENUS REMEDIES 5-YR ANALYSIS

COMPARE VENUS REMEDIES WITH

MARKET STATS